Clinical and Demographic Forms of Vulval Dermatoses and their Impact on Quality of Life: A Tertiary Care Study

Main Article Content

Mohak Arora
Nikam Balkrishna
Jamale Varsha

Abstract

Objective: This study's objective was to examine the clinical and demographic aspects of vulval dermatoses as well as how they affect patients' quality of life (QoL) in a tertiary care setting.


Methods: The study comprised 175 individuals with vulval dermatoses in total. Recorded information included demographic details, clinical diagnoses, presenting symptoms, and histological findings. To evaluate the impact on QoL, the Dermatology Life Quality Index (DLQI) was employed.


Results: Lichen sclerosus (42.9%), lichen planus (25.7%), contact dermatitis (11.4%), psoriasis (10.3%), eczema (5.7%), and vulvodynia (4.0%) were the most common clinical diagnoses. The most frequent presenting symptom was itching (73.1%). In the majority of cases, histopathological findings confirmed the clinical diagnoses, with lichen sclerosus and lichen planus being the most frequently identified conditions. A moderate influence on quality of life was indicated by the mean DLQI score of 10.2.


Conclusion: This study sheds light on the clinical, demographic, and QoL effects of vulval dermatoses. Itching was the most frequent presenting symptom, and the most frequent diagnoses were lichen sclerosus and lichen planus. These results underline the necessity of thorough management approaches that take into account the psychological and dermatological aspects of vulval dermatoses.

Article Details

How to Cite
Arora, M. ., Balkrishna, N. ., & Varsha, J. . (2023). Clinical and Demographic Forms of Vulval Dermatoses and their Impact on Quality of Life: A Tertiary Care Study. Journal of Coastal Life Medicine, 11(2), 77–83. Retrieved from https://www.jclmm.com/index.php/journal/article/view/902
Section
Articles

References

Tan A, Bieber AK, Stein JA, Pomeranz MK. Diagnosis and management of vulvar cancer: A review. J Am Acad Dermatol. 2019 Dec;81(6):1387-1396. doi: 10.1016/j.jaad.2019.07.055. Epub 2019 Jul 23. PMID: 31349045..

Simonetta C, Burns EK, Guo MA. Vulvar Dermatoses: A Review and Update. Mo Med. 2015;112(4):301-307..

Bunker CB, Neill SM. The genital, perianal, and umbilical regions. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook's Textbook of Dermatology. 9th ed. Oxford: Wiley-Blackwell; 2016. p. 102.19-102.48.

Edwards SK, Bunker CB, Ziller F, van der Meijden WI. 2013 European guideline for the management of balanoposthitis. Int J STD AIDS. 2014 Aug;25(9):615-26. doi: 10.1177/0956462414533099. Epub 2014 May 14. PMID: 24828553..

Khurana A, Tandon S, Marfatia YS, Madnani N. Genital lichen planus: An underrecognized entity. Indian J Sex Transm Dis AIDS. 2019;40(2):105-112. doi:10.4103/ijstd.IJSTD_45_19.

Corazza M, Schettini N, Zedde P, Borghi A. Vulvar Lichen Sclerosus from Pathophysiology to Therapeutic Approaches: Evidence and Prospects. Biomedicines. 2021;9(8):950. Published 2021 Aug 3. doi:10.3390/biomedicines9080950.

Wijaya M, Lee G, Fischer G. Quality of life of women with untreated vulval lichen sclerosus assessed with vulval quality of life index (VQLI). Australas J Dermatol. 2021 May;62(2):177-182. doi: 10.1111/ajd.13530. Epub 2021 Jan 28. PMID: 33508152.

Vittrup G, Mørup L, Heilesen T, Jensen D, Westmark S, Melgaard D. Quality of life and sexuality in women with lichen sclerosus: a cross-sectional study. Clin Exp Dermatol. 2022 Feb;47(2):343-350. doi: 10.1111/ced.14893. Epub 2021 Nov 2. PMID: 34388289..

Goldstein AT, Creasey A, Pfau R, et al. Vulvodynia: assessment and treatment. J Sex Med. 2016;13(4):572-590.

Fruchter R, Melnick L, Pomeranz MK. Lichenoid vulvar disease: A review. Int J Womens Dermatol. 2017;3(1):58-64. Published 2017 Mar 27. doi:10.1016/j.ijwd.2017.02.017.

Smith YR, Haefner HK. Vulvar lichen planus: pathophysiology and treatment. Am J Clin Dermatol. 2004;5(2):105-125.

Abramov Y, Elchalal U, Abramov D, Goldfarb A, Schenker JG. Surgical treatment of vulvar lichen sclerosus: a review. Obstet Gynecol Surv. 1996 Mar;51(3):193-9. doi: 10.1097/00006254-199603000-00023. PMID: 8677058.

Raef HS, Elmariah SB. Vulvar Pruritus: A Review of Clinical Associations, Pathophysiology and Therapeutic Management. Front Med (Lausanne). 2021 Apr 7;8:649402. doi: 10.3389/fmed.2021.649402. PMID: 33898486; PMCID: PMC8058221.

Woelber L, Prieske K, Mendling W, Schmalfeldt B, Tietz HJ, Jaeger A. Vulvar pruritus-Causes, Diagnosis and Therapeutic Approach. Dtsch Arztebl Int. 2020 Feb 21;116(8):126-133. doi: 10.3238/arztebl.2020.0126. PMID: 32181734; PMCID: PMC7081372.

Stewart KM. Clinical care of vulvar pruritus, with emphasis on one common cause, lichen simplex chronicus. Dermatol Clin. 2010 Oct;28(4):669-80. doi: 10.1016/j.det.2010.08.004. PMID: 20883911.